fluphenazine depot has been researched along with fluphenazine in 301 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 190 (63.12) | 18.7374 |
| 1990's | 74 (24.58) | 18.2507 |
| 2000's | 23 (7.64) | 29.6817 |
| 2010's | 12 (3.99) | 24.3611 |
| 2020's | 2 (0.66) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Goude, F; Lanza, JP; Lanza, M | 1 |
| Pawelkiewicz, K; Sekrecki, T | 1 |
| Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
| Krska, J; Sampath, G; Shah, A; Soni, SD | 1 |
| Bergen, J; Berry, G; Kitchin, R | 1 |
| Sachdev, P; Tang, WM | 1 |
| Dawson, ME; Gitlin, M; Goldstein, MJ; Mintz, J; Nuechterlein, KH; Snyder, KS; Ventura, J; Yee, CM | 1 |
| Gitlin, M; Hardesty, JP; Nuechterlein, KH; Ventura, J | 1 |
| Brown, WA; Friedhoff, LT; Glazer, WM; Marder, SR | 1 |
| Andren, P; Crossman, AR; Gunne, LM; Liminga, U; Mitchell, IJ | 1 |
| Friedman, JH | 1 |
| Dutta, D; Kerr, TA; McClelland, HA; Metcalfe, AV; Watson, P | 1 |
| Aravagiri, M; Chabert, N; Marder, SR; Van Putten, T; Wirshing, WC | 1 |
| Samuel, G | 1 |
| Aravagiri, M; Hawes, EM; Hubbard, JW; Marder, SR; McKay, G; Midha, KK; Mintz, J; Van Putten, T | 1 |
| Sachdev, P | 1 |
| Blázquez Izquierdo, J; Corral Rosillo, J; Delgado Martín, JA; Gómez Ruiz, JJ; Gómez Vegas, A; Prieto Chaparro, L; Salinas Casado, J; Silmi Moyano, A | 1 |
| Brownlee, M; Soni, SD | 1 |
| Kravchenko, NE; Ushakov, IuV | 1 |
| Chen, GQ; Deng, MZ; Phillips, MR | 1 |
| Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV | 1 |
| Basu, J | 1 |
| Khanna, N; Khanna, R | 1 |
| Altamura, AC; Girardi, T; Mauri, MC; Panetta, B | 1 |
| Balasová, G; Drtil, J; Duchácková, K; Jandová, E | 1 |
| Hadzović, S; Milić-Askrabić, J; Samardzić, Z | 1 |
| Crocq, MA; Durst, P; Macher, JP; Mokrani, MC; Schuff, N | 1 |
| Commander, M; Dean, C | 1 |
| Krystal, AD; McEvoy, JP | 1 |
| Crismon, ML; Wasan, S | 1 |
| Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG | 1 |
| Geller, J | 1 |
| Gingerich, S; Mason, SE; Siris, SG | 1 |
| McCreadie, RG; Whitehead, A; Wiles, DH | 1 |
| Clovis, WL | 1 |
| Gloersen, BA; Inderbitzin, LB; Lewine, RR; McDonald, SC; Rosen, PB; Vidanagama, BP | 1 |
| Amrung, S; Davis, CM; Fidone, GS; Hernandez, JM; Jann, MW | 1 |
| Annable, L; Campbell, W; Chouinard, G | 1 |
| Brown, W; Faraone, SV; Green, AI; Tsuang, MT; Yin, P | 1 |
| Kehoe, R; Young, A | 1 |
| Dasberg, H; Greenberg, D; Heresco-Levy, U; Lerer, B; Wittman, L | 1 |
| Gill, RC; Leong, OK; Tay, WK; Wong, KE | 1 |
| Neehall, J | 1 |
| Ueki, S; Yamamoto, T | 1 |
| Aronson, A; Sellew, AP; Siris, SG | 1 |
| Kong, DS; Yeo, SH | 2 |
| Hirsch, SR; Jolley, AG | 1 |
| Cooper, SJ; Doherty, MM; King, DJ | 1 |
| Brotman, AW; McCormick, S | 1 |
| Adan, F; Siris, SG | 1 |
| Schiff, AA | 2 |
| Drtil, J | 1 |
| Cutler, J; Gingerich, S; Lang, MP; Mason, S; Owen, K; Siris, SG | 1 |
| Achkova, P | 1 |
| Dobiásová, A; Faltus, F; Filip, V; Hanáková, S; Janecková, E; Karen, P; Posmurová, M; Raboch, J | 1 |
| Beal, MF; Carr, DB; Fisher, J; Martin, JB | 1 |
| Borenstein, M; Kane, JM | 1 |
| Dubnitskaia, EB; Maksimov, VI; Novikov, VN; Smulevich, AB; Vorob'ev, VIu | 1 |
| Kane, JM | 3 |
| Simpson, GM; Yadalam, K | 1 |
| Domino, EF | 1 |
| Baldessarini, RJ; Teicher, MH | 1 |
| Ardern, M; Kolakowska, T; Williams, AO | 1 |
| Lazarus, A | 1 |
| Jauregui, J; Kelley, AE; Nadaud, D; Stinus, L | 1 |
| Ardern, M; Kolakowska, T; Reveley, MA; Williams, AO | 1 |
| Marder, SR; Van Putten, T | 1 |
| Niss, AI; Shibakova, TL | 1 |
| Carotti, P; Merli, R | 1 |
| David, I; Filip, V; Hellerová, P | 1 |
| James, WA; Pary, R; Tobias, CR; Turns, DM | 1 |
| Fombonne, E; Fuhrer, R; Peron-Magnan, P; Simon, P | 1 |
| Dinan, TG | 1 |
| Bartkó, G; Herczeg, I; Zádor, G | 1 |
| Ba, B; Durand, A; Gouezo, F; Hou, N; Jørgensen, A; Viala, A | 1 |
| Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E | 1 |
| Boza, RA; Dominguez, F; Milanes, F; Slater, V; Starkey, T | 1 |
| Genz, A | 1 |
| Asarnow, RF; Marder, SR; Mintz, J; Van Putten, T; Zimmerman, KE | 1 |
| Adan, F; Aronson, A; Casey, E; Cohen, M; Mandeli, J; Siris, SG | 1 |
| Hawes, EM; Hubbard, JW; Marder, SR; May, PR; McKay, G; Midha, KK; Mintz, J; Van Putten, T | 2 |
| Sachdev, PS | 1 |
| Choras, PT; Cole, JO; Fulwiler, CE; Pope, HG | 1 |
| Altamura, AC; Cazzullo, CL; Guercetti, G; Mauri, MC | 1 |
| Hawes, EM; Hubbard, JW; Marder, SR; May, PR; McKay, G; Midha, KK; Van Putten, T | 1 |
| Ellison, GD; Levin, ED; See, RE | 1 |
| Ehle, G; Klein, A | 1 |
| Imlah, NW; Kitamura, T; McGovern, DA; Schiff, AA; Wiles, D | 1 |
| Siris, SG; Strahan, A | 1 |
| Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP | 1 |
| Arndt, DC; Barchas, JD; Faull, KF; Ratner, AV; Young, SW | 1 |
| Bamrah, JS; Schiff, AA; Soni, SD; Wiles, D | 1 |
| Casey, E; Cooper, TB; Frechen, K; Mandell, J; Sellew, AP; Siris, SG | 1 |
| Gottlieb, GL; Gur, RC; McAllister, TW | 1 |
| McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH | 1 |
| Adan, F; Casey, E; Cooper, TB; Lee, A; Mandeli, J; Siris, SG | 1 |
| Fogelson, D; Gitlin, MJ; Midha, KK; Nuechterlein, K | 1 |
| Blumenthal, R; Borenstein, M; Kane, J; Kreisman, D; Reardon, G; Rifkin, A; Woerner, M | 1 |
| Simpson, GM; Yadalam, KG | 1 |
| Martin, DT; Swash, M | 1 |
| Hirschberg, E | 1 |
| Ginchereau, EH; Munetz, MR; Toenniessen, LM | 1 |
| Hunter, L; Turbott, J; Villiger, J | 1 |
| Fuentenebro, F; Irwin, M; Marder, SR; Yuwiler, A | 1 |
| Davis, CM; Ereshefsky, L; Jann, MW; Saklad, SR | 1 |
| Wistedt, B | 1 |
| Cookson, JC; Gribbon, D; Kennedy, NM | 1 |
| Lebell, M; Marder, SR; May, PR; McKenzie, J; Mintz, J; Van Putten, T | 1 |
| Cooper, TB; Fagerstrom, R; Morgan, V; Rifkin, A; Siris, SG | 1 |
| Bailie, GR; Krenzelok, EP; Lesar, T; Nelson, MV | 1 |
| Berkman, CS; Glazer, WM; Maynard, C | 1 |
| Anderson, CM; Hogarty, GE; Reiss, DJ | 1 |
| Adan, F; Aronson, A; Cohen, M; Fasano-Dube, B; Mandeli, J; Siris, SG | 1 |
| Hietala, J; MacDonald, E; Scheinin, M; Syvälahti, E | 1 |
| Gelenberg, AJ | 1 |
| Cassino, T; Heiman, J; Shupe, J; Sklebar, HT; Spellman, N | 1 |
| Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 1 |
| Burrows, GD; Kimber, NM; Marriott, PF; Norman, TR | 1 |
| Coyle, J; Jayaram, G; Tune, L | 1 |
| Abramova, LI; Gushanskiĭ, EL | 1 |
| Grover, D; Keshavan, MS; Yeragani, VK | 1 |
| Blum, A | 1 |
| Chalmers, NR; Locke-Haydon, J | 1 |
| Dawson, ME; Fogelson, D; Gitlin, M; Nuechterlein, KH; Rappe, S; Snyder, KS | 1 |
| Diamond, JM; Hayes, DD | 1 |
| Dietzel-Rogan, M; Lesch, OM; Musalek, M; Rajna, P; Rustembegovich, A; Schjerve, M; Walter, H | 1 |
| Bamber, RW; Barnes, TR; Curson, DA; Duffy, JC; Hirsch, SR; Platt, SD | 3 |
| Altamura, AC; Curry, SH; Montgomery, S; Wiles, DH | 1 |
| Casper, RC; Chang, SS; Davis, JM; Dysken, MW; Janicak, PG; Javaid, JI | 1 |
| Hinterhuber, H; Neumann, R | 1 |
| Blue, MG; Fraley, DS; Noro, S; Schneider, SM | 1 |
| Holt, RJ; Zengotita, HE | 1 |
| Doddi, SR; Hall, KS; Reardon, GT; Rifkin, A; Siris, SG; Strahan, A | 1 |
| Burch, NR; Davis, CM; Ereshefsky, L; Jann, MW; Richards, AL; Saklad, SR | 1 |
| Biever, J; Cadieux, RJ; Kales, A; Kales, JD; Mann, LD | 1 |
| Brown, WA; Silver, MA | 1 |
| Emson, PC; Goedert, M; Iversen, SD | 1 |
| Castellani, S | 1 |
| Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B | 1 |
| Bonomo, V; Parisi, R; Rapisarda, V | 1 |
| Chouinard, G; Cohen, BM; Jones, B; Sommer, BR; Waternaux, C | 1 |
| Gift, T; Plum, K; Price, M | 1 |
| Shevchenko, VV | 1 |
| Aranovich, AG; Gamburg, AL; Kotel'kevich, IuN; Omorokov, BM; Rasniuk, VA | 1 |
| Gamble, SJ; Waddington, JL | 1 |
| Annable, L; Chouinard, G; Ross-Chouinard, A | 1 |
| Blake, IM; Braddock, LE | 1 |
| Balon, R; Kabesh, Ia; Papezhova, G | 1 |
| Gelenberg, AJ; Mandel, MR; Mieske, M; Schooler, NR; Severe, JB | 1 |
| Singh, SV | 1 |
| Kane, JM; Kinon, B; Wegner, J; Weinhold, P; Woerner, M | 1 |
| Bartels, M; Riffel, B; Stöhr, M | 1 |
| Fidecka, S; Langwiński, R | 1 |
| Bourne, RC; Cross, AJ; Gamble, SJ; Waddington, JL | 1 |
| Goldberg, HL; van der Kolk, BA | 1 |
| Walker, CA | 1 |
| Johnson, DA; Ludlow, JM; Pasterski, G; Street, K; Taylor, RD | 1 |
| Awad, AG; Hogan, TP | 1 |
| Lapierre, YD; von Frenckell, R | 1 |
| Müller, P | 1 |
| Batth, S; Gelfand, R; Gray, R; Lapierre, YD; Oyewumi, LK | 1 |
| Dencker, SJ | 1 |
| Hogarty, GE | 1 |
| Berkowitz, R; Eberlein-Fries, R; Kuipers, L; Leff, J; Sturgeon, D | 1 |
| Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR | 1 |
| Ostow, M | 1 |
| Beal, MF; Martin, JB | 1 |
| Ba, B; Berda, C; D'Agostino, N; Dufour, H; Durand, A; Hou, N; Jørgensen, A; Viala, A | 1 |
| Asarnow, RF; Marder, SR; Van Putten, T | 1 |
| Bacopoulos, NG; Bustos, G; Redmond, DE; Roth, RH | 1 |
| Kane, JM; Nayak, D; Quitkin, F; Ramos-Lorenzi, J; Rifkin, A | 1 |
| November, M; Reardon, GT; Rifkin, A; Siris, SG | 1 |
| Kane, JM; Ramos-Lorenzi, J; Reardon, G; Rifkin, A; Sarantakos, S; Schiebel, D; Woerner, M | 1 |
| Ranta, J; Wistedt, B | 1 |
| Mackie, M; McCreadie, RG; McKane, JP | 1 |
| Katz, K; Shepherd, M; Watt, DC | 1 |
| Barnes, TR; Curson, DA; Milavic, G; Platt, SD | 1 |
| Glazer, WM | 2 |
| Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G | 1 |
| Cheung, HK; Yu, EC | 1 |
| Shoyab, M | 1 |
| Faltico, G; Lebell, M; Marder, SR; May, PR; McKenzie, J; Mintz, J; Van Putten, T | 1 |
| Basso, L; Michel, G; Vásquez, R | 1 |
| Neumann, J; Waldmann, KD | 1 |
| Hiep, A; Marriott, P; Pansa, M | 1 |
| Adler, S; Coyle, J; Granato, JE; Karim, AH; Krumholz, A; Ringel, A; Stern, BJ | 1 |
| Palmstierna, T; Wistedt, B | 1 |
| Pope, HG; Zubenko, G | 1 |
| Ngui, PW | 1 |
| Mattes, JA; Nayak, D | 1 |
| Arató, M; Perényi, A | 1 |
| Deiser, R; Schindler, R | 1 |
| Aranovich, AG; Gamburg, AL; Rasniuk, VA; Vol'fson, VL | 1 |
| Frances, A; Shear, MK; Weiden, P | 1 |
| Gaby, N; Israel, JR; Lefkowitz, D | 1 |
| Brenner, R; Cooper, TB; Lieberman, JA; Rifkin, AE; Siris, SG | 1 |
| Polácek, J | 1 |
| Waddington, JL | 1 |
| Aderounmu, AF; Odejide, OA | 1 |
| Kidd, J; Mackie, M; McCreadie, R; Morrison, D | 1 |
| Merali, Z; Toth, G | 1 |
| Hwu, HG; Nakra, BR | 1 |
| Cohen, BM; Cooper, TB; Friedman, MJ; Harris, PQ | 1 |
| Landmark, J; Merskey, H; Russell, N; Turpin, T | 1 |
| Fang, VS; Goode, DJ; Meltzer, HY | 1 |
| Furukawa, T; Yamada, K | 1 |
| Steiner, S | 1 |
| Cervantes, J; Csernansky, JG; Grabowski, K; Kaplan, J; Yesavage, JA | 1 |
| Filotto, JF | 1 |
| Nagy, C; Steiner, S | 1 |
| Chee, KT; Ong, TC; Tan, CT | 1 |
| Zhang, YF | 1 |
| Merali, Z | 1 |
| Blazek, J; Rektor, L | 1 |
| Goldstein, MJ; Lebell, MB; Marder, SR; Mintz, J; Mintz, LI; Tompson, MC | 1 |
| Gunne, LM; Liminga, U | 1 |
| Gunne, LM; Johnson, AE; Lidén, A; Liminga, U; Lindefors, N; Wiesel, FA | 1 |
| Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O | 1 |
| Gillies, P; McLean, S; Miller, RS; Peterson, GM; Westhead, TT | 1 |
| Bartone, P; Carter, M; Cooley, S; DiBarry, AL; Hammill, K; Hogarty, GE; McEvoy, JP; Munetz, MR; Perel, J; Ulrich, RF | 1 |
| Drummer, OH; Gall, JA; Landgren, AJ | 1 |
| Bermanzohn, PC; Mason, SE; Shuwall, MA; Siris, SG | 1 |
| Brücke, T; Deecke, L; Fischer, P; Harasko-van der Meer, C; Podreka, I; Wenger, S | 1 |
| Egan, GJ; Gloersen, BA; Inderbitzin, LB; Lewine, RR; Scheller-Gilkey, G; Swofford, CD; Vidanagama, BP; Waternaux, C | 1 |
| Gaskell, K; Reed, P; Soni, SD | 1 |
| Cernovsky, ZZ; Landmark, J; Merskey, H | 1 |
| Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N | 1 |
| Cape, G | 1 |
| Shedlack, KJ; Soldato-Couture, C; Swanson, CL | 1 |
| Dorevitch, A; Durst, R; Fraenkel, Y | 1 |
| Lee, JH; Schooler, NR; Schulz, SC; Severe, JB; Weiden, P | 1 |
| Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM | 1 |
| de Nesnera, AP | 1 |
| Brown, WA; Dasberg, H; Greenberg, D; Heresco-Levy, U; Lerer, B | 1 |
| Lerner, G; Pollack, S; Robinson, D; Woerner, MG | 1 |
| Hawton, K; Hewitt, J; Kingsbury, S; Mistry, H; Roberts, D; Ware, C; Weitzel, H | 1 |
| Inderbitzin, LB; Kasckow, JW; Scheller-Gilkey, G; Swofford, CD | 1 |
| Little, JD | 1 |
| Adlersberg, S; Averbuch, E; Gonen, N; Mester, R; Spivak, B; Weizman, A | 1 |
| Eckman, TA; Johnston, K; Lebell, M; Liberman, RP; Marder, SR; McKenzie, J; Mintz, J; Wirshing, WC; Zimmerman, K | 1 |
| Hubbard, JW; Luo, JP; Midha, KK | 3 |
| Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
| Bellack, AS; Frances, A; Glick, ID; Hargreaves, WA; Jacobs, M; Kane, JM; Keith, SJ; Lieberman, JA; Mance, R; Matthews, SM; Ninan, PT; Schooler, NR; Severe, JB; Simpson, GM; Woerner, MG | 1 |
| Benazzi, F | 1 |
| Brown, WA; Greenberg, D; Heresco-Levy, U; Javitt, DC; Lerer, B | 1 |
| Joubert, G; Stevens, M; van der Merwe, H; Verster, GC | 1 |
| Morris, SE; Nuechterlein, KH; White, PM; Yee, CM | 1 |
| Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD | 1 |
| Breier, AF; Buchanan, RW; Carpenter, WT; Kirkpatrick, B; Lann, HD; Summerfelt, AT | 1 |
| Glick, ID; Jacobs, M; Ninan, PT; Odbert, CL; Robinson, D; Schulz, SC; Thompson, PA; Weiden, PJ; Yadalam, K | 1 |
| Arana, GW; Gerding, LB; Labbate, LA; Measom, MO; Santos, AB | 1 |
| Cathcart, S; Sachdev, P; Saharov, T | 1 |
| Dernovsek, MZ; Tavcar, R | 1 |
| Adams, CE; Eisenbruch, M | 1 |
| Camp-Lifshitz, J; Lee, K; Lifshitz, K; Linn, GS; O'Keeffe, RT | 1 |
| Aravagiri, M; Bartzokis, G; Fogelson, DL; Gitlin, M; Mintz, J; Nuechterlein, K; Subotnik, KL; Ventura, J | 1 |
| Aravagiri, M; Lebell, M; Marder, SR; Mintz, J; Wirshing, DA; Wirshing, WC | 1 |
| Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA | 1 |
| Miller, DD | 1 |
| McCormick, SE; Stoessl, AJ | 1 |
| Conley, RR; Kelly, DL; Love, RC; McMahon, RP | 1 |
| Allahham, A; Mainwaring, DE; Marriott, J; Stewart, P | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Aukst-Margetić, B; Badanjak, A; Margetić, B | 1 |
| Charles, J; Miller, G; Ng, A | 1 |
| Aravagiri, M; Arroyo, LG; Baird, JD; Kenney, DG; Maylin, GA; McGurrin, MK; Rodriguez-Palacios, A; Vengust, M | 1 |
| McEvoy, JP | 1 |
| Arellano, A; Baptista, T; Beaulieu, S; Contreras, Q; Galeazzi, T; Hernández, L; Lacruz, A; Martinez, M; Mendoza, S; Vargas, D | 1 |
| Altshuler, LL; Bartzokis, G; Doi, C; Edwards, N; Gitlin, M; Lieu, C; Lu, PH; Mintz, J; Nuechterlein, KH | 1 |
| Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B | 1 |
| Aukst Margetić, B; Margetić, B | 1 |
| Boddy, RS; Giugni, EA; Limet, NG | 1 |
| Kellams, J; Small, JG | 1 |
| Britvić, D; Ille, T; Stanković, Z; Vuković, O | 1 |
| Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R | 1 |
| Citrome, L; Jaffe, A; Levine, J | 1 |
| Bhattacharji, S; John, SM; Tharyan, A; Venkatesan, S | 1 |
| Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I | 1 |
| Kirk Morton, N; Zubek, D | 1 |
| Ille, T; Stanković, Z | 1 |
| Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T | 1 |
| Benoit, M; Bishop, J; Costello, S; Folker-Calderon, D; Heffron, B; Hurt, L; Negrusz, A; Simpson, L; Taddei, L | 1 |
| Fawkner, L; Fukui, A; Nielssen, O; Walker, K | 1 |
| Adams, CE; Asher, R; David, A; Eisenbruch, M; Jayaswal, A; Maayan, N; Quraishi, SN; Rathbone, J | 1 |
| Schook, MW; Wagman, JD; Wolfe, BA | 1 |
| Kobayashi, R; Nisijima, K; Suda, S; Umino, M | 1 |
| Jamaluddin, R | 1 |
| Azizi, M; Elyasi, F; Kamali, M; Zarghami, M | 1 |
| Imai, T; Nakada, Y; Ohura, K | 1 |
11 review(s) available for fluphenazine depot and fluphenazine
| Article | Year |
|---|---|
Neuroleptic plasma levels.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Perphenazine; Schizophrenia; Thiothixene | 1991 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluphenazine; Humans; Hypotension, Orthostatic; Male; Photosensitivity Disorders; Pigmentation Disorders; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Neurotransmitter; Risk; Sexual Dysfunction, Physiological | 1985 |
Blood levels of neuroleptics: state of the art.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Mental Disorders; Phenothiazines; Research Design; Thioridazine; Thiothixene | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Kinetics; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychotic Disorders; Radioimmunoassay; Radioligand Assay | 1984 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States | 1984 |
Dose response of prophylactic antipsychotics.
Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology | 1993 |
Depot fluphenazine for schizophrenia.
Topics: Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Schizophrenia | 2000 |
Risks versus benefits of different types of long-acting injectable antipsychotics.
Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal | 2006 |
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Randomized Controlled Trials as Topic; Schizophrenia | 2015 |
76 trial(s) available for fluphenazine depot and fluphenazine
| Article | Year |
|---|---|
Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.
Topics: Adolescent; Adult; Attitude to Health; Autonomic Nervous System; Double-Blind Method; Female; Fluphenazine; Humans; Longitudinal Studies; Male; Recurrence; Research Design; Schizophrenia; Schizophrenic Psychology; Stress, Psychological | 1992 |
The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluphenazine; Gas Chromatography-Mass Spectrometry; Humans; Injections, Intramuscular; Male; Middle Aged; Prolactin; Schizophrenia; Schizophrenic Psychology | 1992 |
Psychiatrists and citizens.
Topics: Chronic Disease; Double-Blind Method; Ethics, Medical; Fluphenazine; Humans; Informed Consent; Schizophrenia | 1991 |
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
Topics: Adult; Akathisia, Drug-Induced; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Psychomotor Agitation; Risk Factors; Schizophrenia; Schizophrenic Psychology | 1991 |
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia | 1990 |
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia | 1990 |
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Neuroleptic dose reduction in persistently psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology | 1989 |
A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Thiazines | 1989 |
Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
Topics: Adult; Benztropine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fear; Female; Fluphenazine; Humans; Imipramine; Panic; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1989 |
An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1989 |
The dysphoric syndrome in schizophrenia and its implications for relapse.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Neurotic Disorders; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1989 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Propranolol; Schizophrenia; Schizophrenic Psychology | 1989 |
[Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; History, Ancient; Humans; Male; Schizophrenia | 1985 |
Antipsychotic drug side effects: their relationship to dose.
Topics: Agranulocytosis; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluphenazine; Humans; Hypotension, Orthostatic; Male; Photosensitivity Disorders; Pigmentation Disorders; Psychiatric Status Rating Scales; Psychotic Disorders; Receptors, Neurotransmitter; Risk; Sexual Dysfunction, Physiological | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Comparative study of four evaluation criteria in a clinical trial with schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Fluphenazine; Humans; Middle Aged; Nursing; Psychiatric Status Rating Scales; Psychiatry; Schizophrenia; Thiazines | 1986 |
Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities.
Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluphenazine; Humans; Male; Middle Aged; Psychomotor Performance; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology | 1988 |
Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Topics: Adolescent; Adult; Aged; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Random Allocation; Schizophrenia; Schizophrenic Psychology | 1988 |
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Fluphenazine; Humans; Kinetics; Male; Middle Aged; Schizophrenia | 1986 |
Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
Topics: Adult; Affective Disorders, Psychotic; Benztropine; Clinical Trials as Topic; Drug Interactions; Fluphenazine; Humans; Imipramine; Middle Aged; Schizophrenia; Time Factors; Tropanes | 1988 |
Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Mental Status Schedule; Pilot Projects; Psychiatric Status Rating Scales; Social Behavior Disorders | 1988 |
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia | 1987 |
Persistence of fluphenazine in plasma after decanoate withdrawal.
Topics: Adult; Female; Fluphenazine; Humans; Male; Radioimmunoassay; Schizophrenia; Substance Withdrawal Syndrome | 1988 |
Family attitudes and patient social adjustment in a longitudinal study of outpatient schizophrenics receiving low-dose neuroleptics: the family's view.
Topics: Adolescent; Adult; Attitude; Dose-Response Relationship, Drug; Family; Female; Fluphenazine; Humans; Longitudinal Studies; Male; Middle Aged; Recurrence; Rejection, Psychology; Schizophrenia; Social Adjustment | 1988 |
Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.
Topics: Biological Availability; Clinical Trials as Topic; Drug Evaluation; Fluphenazine; Humans; Kinetics; Mental Disorders; Psychotropic Drugs; Schizophrenia; Therapeutic Equivalency; United States; United States Dept. of Health and Human Services; United States Food and Drug Administration | 1986 |
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1986 |
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1986 |
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.
Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Follow-Up Studies; Humans; Male; Outcome and Process Assessment, Health Care; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1987 |
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Follow-Up Studies; Humans; Imipramine; Male; Outcome and Process Assessment, Health Care; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1987 |
Targeted treatment of depression-like symptoms in schizophrenia.
Topics: Benztropine; Depression; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Schizophrenia | 1987 |
[Social integration of long-term paraphrenic patients with low-dose depot neuroleptic medication].
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment | 1985 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged; Outpatient Clinics, Hospital; Residence Characteristics; Schizophrenia; Schizophrenic Psychology | 1985 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Follow-Up Studies; Hospitalization; Humans; Parkinson Disease, Secondary; Patient Compliance; Schizophrenia; Schizophrenic Psychology | 1985 |
Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Fluphenazine; Follow-Up Studies; Humans; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Behavior; Time Factors | 1985 |
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1985 |
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Schizophrenic Psychology | 1982 |
Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology | 1982 |
A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Fluphenazine; Humans; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1983 |
Low dose medication strategies in the maintenance treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluphenazine; Humans; Long-Term Care; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment | 1983 |
Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Topics: Antipsychotic Agents; Attitude to Health; Behavior Therapy; Clinical Trials as Topic; Family; Family Therapy; Fluphenazine; Humans; Patient Compliance; Patient Readmission; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Social Environment; United States | 1984 |
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Clinical Trials as Topic; Delayed-Action Preparations; Family; Family Therapy; Female; Flupenthixol; Fluphenazine; Follow-Up Studies; Health Education; Humans; Interview, Psychological; Life Change Events; Male; Middle Aged; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; United Kingdom | 1984 |
Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Radioimmunoassay; Schizophrenia; Thioxanthenes | 1984 |
Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia.
Topics: Adult; Aftercare; Double-Blind Method; Female; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1982 |
Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Topics: Adult; Benztropine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Tropanes | 1983 |
Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1983 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Middle Aged; Random Allocation; Recurrence; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Weekly pimozide versus fluphenazine decanoate in schizophrenic out-and day-patients.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Humans; Male; Pimozide; Schizophrenia | 1983 |
The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment.
Topics: Clinical Trials as Topic; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Patient Readmission; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Adjustment | 1983 |
Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
Topics: Adult; Clinical Trials as Topic; Female; Fluphenazine; Humans; Male; Middle Aged; Outpatients; Pimozide; Schizophrenia; Social Behavior | 1983 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States | 1984 |
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia | 1984 |
Costs and benefits of two doses of fluphenazine.
Topics: Adult; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Schedule; Fluphenazine; Humans; Male; Movement Disorders; Patient Dropouts; Psychiatric Status Rating Scales; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology | 1984 |
Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes; Tranquilizing Agents | 1983 |
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.
Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1995 |
Pharmacotherapy of impaired affect in recovering schizophrenic patients.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Anxiety Disorders; Basal Ganglia Diseases; Benztropine; Depressive Disorder; Desipramine; Diagnosis, Differential; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Glycopyrrolate; Humans; Lithium Carbonate; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sex Factors | 1995 |
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Topics: Adult; Antipsychotic Agents; Benztropine; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology | 1994 |
A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Hospitalization; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1994 |
Fluphenazine treatment of DSM-III-R male schizophrenic patients among the Xhosa.
Topics: Adolescent; Adult; Ethnicity; Fluphenazine; Humans; Length of Stay; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Environment; South Africa; Violence | 1994 |
Stabilization and depot neuroleptic dosages.
Topics: Adult; Delayed-Action Preparations; Fluphenazine; Humans; Male; Schizophrenia | 1993 |
Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study.
Topics: Acute Disease; Adult; Clinical Trials as Topic; Combined Modality Therapy; Data Interpretation, Statistical; Delayed-Action Preparations; Double-Blind Method; Family Therapy; Female; Fluphenazine; Humans; Male; Middle Aged; Models, Statistical; Patient Selection; Schizophrenia; Schizophrenic Psychology; Selection Bias | 1996 |
Paracetamol self-poisoning. Characteristics, prevention and harm reduction.
Topics: Acetaminophen; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Overdose; Drug Packaging; England; Female; Fluphenazine; Humans; Life Change Events; Liver Function Tests; Male; Middle Aged; Personality Assessment; Prospective Studies; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Suicide, Attempted | 1996 |
Substance use: a powerful predictor of relapse in schizophrenia.
Topics: Adult; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluphenazine; Humans; Illicit Drugs; Male; Middle Aged; Patient Compliance; Prognosis; Psychotropic Drugs; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1996 |
Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia.
Topics: Adult; Age of Onset; Ambulatory Care; Behavior Therapy; Combined Modality Therapy; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Psychotherapy, Group; Reinforcement, Social; Role Playing; Schizophrenia; Social Adjustment; Social Support; Treatment Outcome | 1996 |
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
Topics: Adolescent; Adult; Ambulatory Care; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Family Therapy; Female; Fluphenazine; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1997 |
Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Recurrence; Schizophrenia; Treatment Outcome | 1997 |
Generic substitution--comparing the clinical efficacy of a generic substitute for fluphenazine decanoate with the original product.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Double-Blind Method; Drugs, Generic; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; South Africa; Therapeutic Equivalency | 1998 |
P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Anxiety; Attention; Cognition; Depression; Evoked Potentials; Female; Fluphenazine; Humans; Inhibition, Psychological; Longitudinal Studies; Male; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 1998 |
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Patient Satisfaction; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Outcome | 1999 |
Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
Topics: Ambulatory Care; Brief Psychiatric Rating Scale; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Placebos; Prodrugs; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1999 |
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Cross-Over Studies; Double-Blind Method; Fluphenazine; Follow-Up Studies; Humans; Injections, Intramuscular; Middle Aged; Recurrence; Schizophrenia; Time Factors | 2001 |
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
Topics: Adult; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Topics: Adult; Antipsychotic Agents; Appetite; Benzodiazepines; Blood Glucose; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Insulin; Insulin Resistance; Male; Olanzapine; Reference Values; Risperidone; Schizophrenia; Weight Gain | 2007 |
218 other study(ies) available for fluphenazine depot and fluphenazine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].
Topics: Animals; Antipsychotic Agents; Caproates; Estrus; Female; Flupenthixol; Fluphenazine; Mammary Glands, Animal; Organ Size; Ovary; Phenothiazines; Pregnancy; Pseudopregnancy; Rats; Thiazines; Uterus | 1979 |
[Depr;essive syndrome in the course of treatment with Mirenil prolongatum].
Topics: Acute Disease; Adult; Delayed-Action Preparations; Depression; Female; Fluphenazine; Humans; Neurotic Disorders; Psychotropic Drugs | 1977 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1992 |
Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Observer Variation; Schizophrenia; Schizophrenic Psychology | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Infusions, Intravenous; Male; Neurologic Examination; Ocular Motility Disorders; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
Life events and schizophrenic relapse after withdrawal of medication.
Topics: Adaptation, Psychological; Adult; Female; Fluphenazine; Humans; Injections, Intramuscular; Life Change Events; Longitudinal Studies; Male; Prospective Studies; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1992 |
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
Topics: Animals; Autoradiography; Blood Glucose; Brain; Brain Mapping; Cebus; Densitometry; Deoxyglucose; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Thalamic Nuclei | 1992 |
"Rubral" tremor induced by a neuroleptic drug.
Topics: Adult; Benztropine; Bromocriptine; Corpus Striatum; Fluphenazine; Humans; Male; Neural Pathways; Red Nucleus; Substantia Nigra; Tremor | 1992 |
Facial dyskinesia: a 16-year follow-up study.
Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Brain; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Facial Muscles; Female; Fluphenazine; Follow-Up Studies; Humans; Neurocognitive Disorders; Neurologic Examination; Neuropsychological Tests; Psychotic Disorders; Risk Factors; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1991 |
Tardive oculogyric crisis and obsessional thoughts.
Topics: Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Middle Aged; Obsessive-Compulsive Disorder; Ocular Motility Disorders; Schizophrenia; Schizophrenic Psychology; Thinking | 1991 |
[Priapism secondary to phenothiazines].
Topics: Adult; Delayed-Action Preparations; Drainage; Fluphenazine; Humans; Male; Middle Aged; Priapism; Recurrence; Thioridazine | 1991 |
Alcohol abuse in chronic schizophrenics: implications for management in the community.
Topics: Adult; Alcohol Drinking; Alcoholism; Chronic Disease; Community Mental Health Services; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; Patient Compliance; Schizophrenia; Schizophrenic Psychology | 1991 |
[Clinico-economical aspects of long-term therapy with moditen-depot].
Topics: Cost-Benefit Analysis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Tolerance; Fluphenazine; Humans; Recurrence; Schizophrenia; Time Factors | 1990 |
Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; China; Confidence Intervals; Delayed-Action Preparations; Female; Fluphenazine; Hospitalization; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Neuroleptic Malignant Syndrome; Prevalence; Prospective Studies; Risk Factors | 1990 |
An unusual presentation of neuroleptic malignant syndrome.
Topics: Adult; Dose-Response Relationship, Drug; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1991 |
Delusions of substitution and diabetes mellitus.
Topics: Blood Glucose; Capgras Syndrome; Delusions; Diabetes Mellitus, Type 2; Fluphenazine; Humans; Middle Aged; Neurocognitive Disorders; Patient Compliance; Schizophrenia, Paranoid | 1991 |
Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia.
Topics: Aged; Basal Ganglia Diseases; Blood Pressure; Electrocardiography; Electroencephalography; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Pulse; Schizophrenia; Schizophrenic Psychology | 1990 |
Is the treatment of tobacco dependence with fluphenazine decanoate a causal treatment?
Topics: Behavior Therapy; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Tobacco Use Disorder | 1990 |
[Extrapyramidal side effects of 2 different formulations of fluphenazine chloride injections].
Topics: Animals; Fluphenazine; Injections; Male; Mice | 1990 |
Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.
Topics: Adult; Brain Chemistry; Fluorine; Fluphenazine; Humans; Magnetic Resonance Spectroscopy; Male; Schizophrenia | 1990 |
Symptomatic trans-sexualism.
Topics: Adult; Delayed-Action Preparations; Delusions; Fluphenazine; Humans; Schizophrenia; Schizophrenic Psychology; Transsexualism | 1990 |
Shared features of neuroleptic malignant syndrome and alcohol abuse complications.
Topics: Adult; Diagnosis, Differential; Ethanol; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Substance Withdrawal Syndrome | 1990 |
Considerations in establishing expiration dates for fluphenazine decanoate multiple-dose vials.
Topics: Drug Labeling; Drug Stability; Fluphenazine | 1990 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Psychotic Disorders | 1990 |
Dosage of fluphenazine.
Topics: Administration, Oral; Delayed-Action Preparations; Drug Administration Schedule; Fluphenazine; Humans; Research Design | 1990 |
Use of extremely low doses of fluphenazine decanoate.
Topics: Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Humans; Mental Disorders; Middle Aged; Schizophrenia | 1990 |
Patients' and caregivers' adaptation to improvement in schizophrenia.
Topics: Adult; Assertiveness; Depressive Disorder; Drug Therapy, Combination; Family; Female; Fluphenazine; Halfway Houses; Home Nursing; Humans; Imipramine; Interpersonal Relations; Male; Middle Aged; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Sick Role; Social Environment | 1990 |
Return of sense of taste with fluphenazine.
Topics: Brain; Dose-Response Relationship, Drug; Fluphenazine; Humans; Injections, Intramuscular; Neurocognitive Disorders; Schizophrenia; Schizophrenic Psychology; Taste | 1989 |
Fluphenazine decanoate: a clinical problem?
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Schizophrenia; Schizophrenic Psychology | 1989 |
Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Intellectual Disability; Neurocognitive Disorders; Schizophrenia; Substance Withdrawal Syndrome | 1989 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Droperidol; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Paranoid Disorders; Psychotic Disorders | 1989 |
Prescribing patterns of neuroactive drugs in 98 schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotropic Drugs; Schizophrenia | 1989 |
Tardive dyskinesia in outpatients on depot phenothiazine.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Mental Disorders; Middle Aged; Schizophrenia | 1989 |
Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats.
Topics: Acoustic Stimulation; Agonistic Behavior; Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Delayed-Action Preparations; Electric Stimulation; Electroencephalography; Fluphenazine; Hypothalamus, Posterior; Male; Mesencephalon; Mice; Motor Activity; Rats; Rats, Inbred Strains | 1989 |
Converting doses of fluphenazine decanoate to oral equivalent.
Topics: Administration, Oral; Chlorpromazine; Fluphenazine; Humans | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1989 |
Dosage of oral and depot fluphenazine.
Topics: Administration, Oral; Delayed-Action Preparations; Fluphenazine; Humans | 1989 |
Treatment of patients dependent on tobacco with fluphenazine decanoate.
Topics: Adult; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Smoking | 1989 |
Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Topics: Adult; Benztropine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Middle Aged; Psychotic Disorders; Tranquilizing Agents | 1989 |
[Possibilities for research on the proton-acceptor action of drug preparations].
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dose-Response Relationship, Drug; Electric Conductivity; Fluphenazine; Haloperidol; In Vitro Techniques; Lipid Bilayers; Methods; Methotrimeprazine; Phospholipids; Protons; Solutions | 1987 |
Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
Topics: Animals; Antipsychotic Agents; beta-Endorphin; Brain Chemistry; Chlorpromazine; Corpus Striatum; Dopamine; Endorphins; Fluphenazine; Haloperidol; Limbic System; Male; Radioimmunoassay; Rats; Rats, Inbred Strains | 1985 |
Compliance in the long-term treatment of schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Humans; Patient Compliance; Recurrence; Schizophrenia | 1985 |
[Intensive psychopharmacologic therapy of slowly-progressive schizophrenia].
Topics: Adult; Antipsychotic Agents; Chlordiazepoxide; Diazepam; Female; Fluphenazine; Humans; Infusions, Parenteral; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Syndrome; Trimeprazine | 1985 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome | 1985 |
Selection of neuroleptic dosage.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1985 |
Tardive dyskinesia and current dose of neuroleptic drugs.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Humans; Middle Aged; Psychotic Disorders; Schizophrenia | 1985 |
Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
Topics: Antipsychotic Agents; Benztropine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
Topics: Animals; Antipsychotic Agents; Enkephalin, Methionine; Flupenthixol; Fluphenazine; Haloperidol; Male; Nucleus Accumbens; Perphenazine; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei; Sulpiride; Time Factors | 1986 |
Tardive dyskinesia in schizophrenics under 60 years of age.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Male; Prognosis; Schizophrenia | 1986 |
[Clinical picture, therapy and rehabilitation of patients with slowly-progressive (psychopath-like) schizophrenia with a loss of work capacity].
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Dibenzazepines; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Male; Middle Aged; Rehabilitation, Vocational; Schizophrenia | 1986 |
[Considerations on the use of long-acting neuroleptics in a mental health center].
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Depression; Fluphenazine; Humans; Injections, Intravenous; Male; Mental Disorders; Mental Health Services; Middle Aged; Schizophrenia; Schizophrenia, Paranoid | 1986 |
[Substitution of fluphenazine decanoate with oxyprothepine decanoate in long-term maintenance therapy in schizophrenia].
Topics: Dibenzothiepins; Female; Fluphenazine; Humans; Male; Schizophrenia | 1986 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Clinical symptomatology and drug compliance in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1988 |
Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1988 |
Effects of neuroleptic treatments on peripheral opioid secretion.
Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Dibenzothiazepines; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Receptors, Opioid; Schizophrenia | 1987 |
Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
Topics: Adult; Antipsychotic Agents; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Schizophrenic Psychology | 1988 |
[Tardive dystonia--a case report on therapy and metaphylaxis].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Fluphenazine; Humans; Male; Psychotic Disorders | 1988 |
Lithium potentiation of neuroleptic-related extrapyramidal side effects.
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lithium; Lithium Carbonate; Time Factors | 1986 |
Apparent neuroleptic malignant syndrome with clozapine and lithium.
Topics: Adult; Bipolar Disorder; Clozapine; Dibenzazepines; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Lithium Carbonate; Male; Neuroleptic Malignant Syndrome | 1986 |
Fluphenazine decanoate in acute and maintenance therapy of schizophrenia.
Topics: Acute Disease; Adult; Female; Fluphenazine; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1987 |
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Topics: Fluphenazine; Gas Chromatography-Mass Spectrometry; Humans; Male; Radioimmunoassay; Schizophrenia | 1987 |
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
Topics: Animals; Female; Fluphenazine; Haloperidol; Mouth; Movement; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
[Results of long-term treatment with depot neuroleptics in schizophrenic patients].
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Humans; Long-Term Care; Schizophrenia; Schizophrenic Psychology | 1988 |
Plasma levels of fluphenazine and prolactin in psychiatric patients.
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Personality Disorders; Prolactin; Schizophrenia | 1988 |
Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Topics: Benztropine; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Psychotic Disorders; Recurrence; Schizophrenia; Substance Withdrawal Syndrome | 1988 |
Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
Topics: Administration, Oral; Adult; Diazepam; Drug Therapy, Combination; Fluphenazine; Humans; Injections, Intramuscular; Male; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid | 1988 |
19F magnetic resonance imaging and spectroscopy of a fluorinated neuroleptic ligand: in vivo and in vitro studies.
Topics: Animals; Brain; Chemical Phenomena; Chemistry; Fluphenazine; Injections, Intramuscular; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
Topics: Adolescent; Adult; Chronic Disease; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Massage; Middle Aged; Physical Exertion; Schizophrenia | 1988 |
Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluphenazine; Humans; Hydroxylation; Imipramine; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1988 |
Changing from oral to depot fluphenazine.
Topics: Administration, Oral; Body Weight; Drug Administration Schedule; Fluphenazine; Humans; Schizophrenia | 1988 |
Muscle pathology in the neuroleptic malignant syndrome.
Topics: Adult; Fluphenazine; Humans; Male; Muscles; Neuroleptic Malignant Syndrome; Procyclidine; Psychotic Disorders | 1987 |
Long persisting drug-induced parkinsonism--a case report.
Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Fluphenazine; Humans; Parkinson Disease, Secondary | 1987 |
Tardive dyskinesia complicated by hyperthyroidism.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Psychotic Disorders; Thyrotoxicosis | 1987 |
Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Electrocardiography; Female; Flupenthixol; Fluphenazine; Heart; Humans; Male; Middle Aged; Prolactin; Radioligand Assay; Schizophrenia; Thioxanthenes | 1987 |
L-5-Hydroxytryptophan-induced delirium.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Delirium; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Hallucinations; Humans; Male; Schizophrenia | 1986 |
Unusual treatment response of a severe dystonia to diphenhydramine.
Topics: Adult; Benztropine; Delayed-Action Preparations; Diphenhydramine; Dystonia; Fluphenazine; Humans; Male; Mental Disorders | 1987 |
Injection site leakage of depot neuroleptics: intramuscular versus subcutaneous injection.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Body Constitution; Female; Fluphenazine; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Mental Disorders; Middle Aged; Muscles; Skin; Tissue Distribution | 1987 |
Family psychoeducation, social skills training, and medication in schizophrenia: the long and short of it.
Topics: Behavior Therapy; Combined Modality Therapy; Family Therapy; Fluphenazine; Humans; Schizophrenia | 1987 |
Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride.
Topics: Animals; Apomorphine; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Fluphenazine; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Vasoconstriction | 1987 |
Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously.
Topics: Fluphenazine; Humans; Injections, Intramuscular; Injections, Subcutaneous | 1987 |
Invitation to compliance. The Prolixin brunch.
Topics: Adult; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; Patient Compliance; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology | 1987 |
Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
Topics: Animals; Bromocriptine; Drug Implants; Estradiol; Female; Fluphenazine; Hyperprolactinemia; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide | 1987 |
Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1987 |
Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Radioligand Assay; Recurrence; Schizophrenia; Schizophrenic Psychology | 1986 |
[Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
Topics: Adult; Affective Symptoms; Ambulatory Care; Antidepressive Agents; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Movement Disorders; Schizophrenia, Paranoid; Social Adjustment | 1986 |
Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Male; Time Factors | 1986 |
Improvement of phencyclidine-associated psychosis with ECT.
Topics: Adult; Electroconvulsive Therapy; Fluphenazine; Humans; Male; Phencyclidine; Phencyclidine Abuse; Psychoses, Substance-Induced; Violence | 1986 |
Is postpsychotic depression a primary affective disorder?
Topics: Depressive Disorder; Fluphenazine; Humans; Psychotic Disorders; Schizophrenia | 1986 |
Effects on the behavior of infant common marmosets (Callithrix jacchus) of separation from caregivers and of drug-induced reduction in caregiver responsiveness.
Topics: Animals; Callithrix; Female; Fluphenazine; Male; Maternal Deprivation; Paternal Deprivation; Psychosocial Deprivation; Sibling Relations; Social Behavior | 1986 |
Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia.
Topics: Adult; Emotions; Family; Female; Fluphenazine; Humans; Male; Recurrence; Schizophrenia; Schizophrenic Psychology | 1986 |
A case of neuroleptic malignant syndrome in a mentally retarded adolescent.
Topics: Adolescent; Aggression; Fluphenazine; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome | 1986 |
Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
Topics: Adolescent; Adult; Chromatography, Gas; Female; Fluphenazine; Humans; Male; Schizophrenia | 1985 |
[Depressive syndromes within the scope of schizophrenic psychoses].
Topics: Depressive Disorder; Fluphenazine; Hallucinations; Humans; Long-Term Care; Male; Models, Psychological; Psychotic Disorders; Schizophrenia; Syndrome | 1985 |
Successful treatment of neuroleptic malignant syndrome with sodium nitroprusside.
Topics: Combined Modality Therapy; Female; Ferricyanides; Fluphenazine; Humans; Loxapine; Middle Aged; Neuroleptic Malignant Syndrome; Nitroprusside; Vasoconstriction | 1986 |
Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect.
Topics: Adult; Blood Coagulation Disorders; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Splenomegaly; Time Factors | 1986 |
Stability of the postpsychotic depression syndrome.
Topics: Adult; Depressive Disorder; Female; Fluphenazine; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; Time Factors | 1986 |
Effects of smoking on fluphenazine clearance in psychiatric inpatients.
Topics: Adult; Female; Fluphenazine; Humans; Kinetics; Male; Metabolic Clearance Rate; Psychotic Disorders; Smoking | 1985 |
Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.
Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Narcolepsy; Patient Compliance; Psychotherapy; Schizophrenia, Paranoid; Social Adjustment; Trifluoperazine | 1985 |
Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Radioligand Assay; Schizophrenia; Schizophrenic Psychology | 1985 |
The effects of chronic neuroleptic treatment on neurotensin-like immunoreactivity in the rat central nervous system.
Topics: Animals; Central Nervous System; Fluphenazine; Male; Neurotensin; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains | 1985 |
Catatonia associated with phenylpropanolamine overdose and fluphenazine treatment: case report.
Topics: Benztropine; Caffeine; Catatonia; Fluphenazine; Humans; Male; Middle Aged; Phenylpropanolamine; Receptors, Dopamine | 1985 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine | 1985 |
Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Regression Analysis; Schizophrenia | 1985 |
Depot fluphenazine and plasma prolactin.
Topics: Drug Tolerance; Female; Fluphenazine; Humans; Male; Prolactin; Schizophrenia; Sex Factors | 1985 |
[Use of moditen-depot in the overall treatment of alcoholism].
Topics: Alcoholism; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Psychotherapy | 1980 |
[Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Depression; Dibenzazepines; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotropic Drugs; Remission, Spontaneous; Schizophrenia, Paranoid | 1980 |
Prolonged dopamine receptor blockade in rats after termination of long-term depot fluphenazine.
Topics: Animals; Delayed-Action Preparations; Fluphenazine; Humans; Male; Rats; Receptors, Dopamine; Schizophrenia; Stereotyped Behavior | 1981 |
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1981 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Schizophrenia, Paranoid | 1982 |
Fluphenazine decanoate and tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Humans | 1982 |
Lithium carbonate/fluphenazine decanoate producing irreversible brain damage.
Topics: Adult; Bipolar Disorder; Brain; Brain Diseases; Drug Synergism; Dysarthria; Female; Fluphenazine; Humans; Lithium; Lithium Carbonate; Speech Disorders | 1982 |
A prospective study of tardive dyskinesia development: preliminary results.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Lithium; Male; Middle Aged; Prospective Studies; Risk; Time Factors | 1982 |
[Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Flupenthixol; Fluphenazine; Humans; Long-Term Care; Male; Schizophrenia, Paranoid; Torticollis | 1982 |
[Delayed-action neuroleptics and analgesia].
Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Male; Mice; Pain; Rats; Thiazines | 1980 |
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Aftercare of schizophrenic patients: pharmacotherapy and consistency of therapists.
Topics: Administration, Oral; Adolescent; Adult; Aftercare; Antipsychotic Agents; Fluphenazine; Follow-Up Studies; Humans; Middle Aged; Professional-Patient Relations; Psychiatric Status Rating Scales; Psychotherapy; Schizophrenia; Schizophrenic Psychology; Social Adjustment | 1983 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1983 |
Pharmacotherapy and suicide risk in schizophrenia.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Risk; Schizophrenia; Suicide | 1983 |
AMDP psychopathology factors in chronic schizophrenia: a clinical trial of two long-acting neuroleptics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thiazines | 1983 |
[What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Fluphenazine; Humans; Long-Term Care; Prognosis; Recurrence; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology | 1983 |
Abnormal involuntary movements in patients on long-acting neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology | 1983 |
The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Biological Availability; Chronic Disease; Delayed-Action Preparations; Drug Utilization; Fluphenazine; Humans; Injections, Intramuscular; Patient Compliance; Psychotic Disorders; Risk; Scandinavian and Nordic Countries; Schizophrenia | 1984 |
Standard v optimal dose.
Topics: Ambulatory Care; Antipsychotic Agents; Drug Administration Schedule; Fluphenazine; Humans; Schizophrenia | 1984 |
Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Male; Peptides; Pimozide; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Information processing and neuroleptic response in acute and stabilized schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Cognition; Fluphenazine; Haloperidol; Humans; Male; Pattern Recognition, Visual; Schizophrenia; Schizophrenic Psychology | 1984 |
Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chlorocebus aethiops; Dopamine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Serotonin; Tyrosine 3-Monooxygenase | 1982 |
Effect of 1050 mg fluphenazine decanoate given intramuscularly over six days.
Topics: Adult; Delayed-Action Preparations; Female; Fluphenazine; Humans; Injections, Intramuscular | 1983 |
Enhancement by fluphenazine of dimethylbenz[a]-anthracene-induced mammary tumorigenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Drug Synergism; Female; Fluphenazine; Mammary Neoplasms, Experimental; Papilloma; Rats; Rats, Inbred Strains | 1983 |
[Follow-up study of patients treated with depot phenothiazines in Valparaiso, Chile].
Topics: Adolescent; Adult; Aged; Chile; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Mental Disorders; Mental Health Services; Middle Aged; Schizophrenia | 1981 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology | 1984 |
Intervals between long acting neuroleptics: outcome and re-admission variables.
Topics: Age Factors; Chronic Disease; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Patient Readmission; Recurrence; Schizophrenia; Sex Factors; Time Factors | 1984 |
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Drug Therapy, Combination; Fluphenazine; Humans; Male; Schizophrenia | 1983 |
Management of a case of neuroleptic malignant syndrome with bromocriptine.
Topics: Adult; Antiparkinson Agents; Autonomic Nervous System Diseases; Bromocriptine; Fever; Fluphenazine; Humans; Male; Muscle Rigidity | 1983 |
[Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia | 1983 |
Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives.
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Humans; Lithium; Middle Aged; Psychotic Disorders; Recurrence; Schizophrenia | 1984 |
Fluphenazine and tardive dyskinesia.
Topics: Delayed-Action Preparations; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Schizophrenia | 1984 |
[The course of long-term care with fluphenazine decanoate (Dapotum D)].
Topics: Fluphenazine; Humans; Long-Term Care; Mental Disorders; Middle Aged | 1980 |
[Various aspects of current treatment of patients with alcoholic delirium].
Topics: Adult; Alcoholism; Amitriptyline; Disulfiram; Fluphenazine; Humans; Male; Methotrimeprazine; Middle Aged; Perphenazine; Placebos; Psychotropic Drugs; Suggestion; Trifluoperazine | 1983 |
Suicide associated with akathisia and depot fluphenazine treatment.
Topics: Adult; Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Suicide | 1983 |
Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged; Schizophrenia; Schizophrenia, Paranoid | 1982 |
Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Delayed-Action Preparations; Depression; Drug Interactions; Drug Therapy, Combination; Female; Fluphenazine; Heart; Humans; Imipramine; Male; Schizophrenia | 1982 |
[Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Topics: Adult; Aged; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Humans; Male; Middle Aged; Psychotic Disorders; Schizophrenia | 1982 |
Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
Topics: Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans | 1982 |
Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
Topics: Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Fluphenazine; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1982 |
Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Middle Aged; Pimozide; Prolactin; Schizophrenia | 1982 |
Effects of fluphenazine decanoate (a long-acting phenothiazine) on serum prolactin and amphetamine-induced behavioural changes.
Topics: Amphetamine; Animals; Behavior, Animal; Dopamine; Drug Interactions; Fluphenazine; Male; Motor Activity; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Catatonic-like syndrome during neuroleptic therapy.
Topics: Aged; Catatonia; Female; Fluphenazine; Haloperidol; Humans | 1982 |
Fluphenazine blood levels and clinical response.
Topics: Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluphenazine; Humans; Radioligand Assay; Schizophrenia | 1982 |
A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
Topics: Adult; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Fluspirilene; Humans; Male; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Spiro Compounds | 1982 |
Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
Topics: Adult; Chlorpromazine; Circadian Rhythm; Female; Fluphenazine; Humans; Male; Prolactin; Psychotic Disorders | 1981 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
[Modification of schizophrenia by intensive neuroleptic therapy and the course of the disease after withdrawal of neuroleptic drugs].
Topics: Adolescent; Adult; Aged; Child; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Middle Aged; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1980 |
Fluphenazine decanoate and tardive dyskinesia: a possible association.
Topics: Adult; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Male; Middle Aged | 1981 |
[Group psychotherapy of chronic schizophrenics in an external milieu].
Topics: Adult; Ambulatory Care; Chronic Disease; Female; Fluphenazine; Humans; Male; Middle Aged; Psychoanalytic Therapy; Psychotherapy, Group; Psychotherapy, Multiple; Schizophrenia; Schizophrenic Psychology; Transference, Psychology | 1981 |
Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate.
Topics: Age Factors; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Humans; Recurrence; Schizophrenia | 1981 |
The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
Topics: Adolescent; Adult; Ambulatory Care; Child; Delayed-Action Preparations; Female; Fluphenazine; Humans; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Retrospective Studies; Schizophrenia | 1981 |
[Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
Topics: Adolescent; Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia | 1981 |
Prolactin levels and amphetamine-induced behavioural changes following fluphenazine decanoate administration.
Topics: Amphetamine; Animals; Behavior, Animal; Fluphenazine; Male; Motor Activity; Prolactin; Rats; Receptors, Dopamine; Tranquilizing Agents | 1981 |
[Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
Topics: Ambulatory Care; Delayed-Action Preparations; Fluphenazine; Humans; Psychotic Disorders | 1980 |
Schizophrenic patients' perceptions of their relatives' attitudes.
Topics: Adult; Affect; Antipsychotic Agents; Black or African American; Family; Fluphenazine; Humans; Middle Aged; Perception; Prognosis; Schizophrenia; Verbal Behavior; White People | 1995 |
Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats.
Topics: Animals; Female; Fluphenazine; Mastication; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Substantia Nigra; Synaptic Transmission | 1993 |
Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Autoradiography; Basal Ganglia; Basal Ganglia Diseases; Brain; Dizocilpine Maleate; Excitatory Amino Acids; Female; Fluphenazine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Situ Hybridization; Muscimol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stereotyped Behavior; Synaptic Transmission | 1994 |
Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluphenazine; Gas Chromatography-Mass Spectrometry; Humans; Injections, Intramuscular; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Patient Compliance; Schizophrenia | 1995 |
Death due to benzhexol toxicity.
Topics: Bronchopneumonia; Cause of Death; Death, Sudden; Dyskinesia, Drug-Induced; Empyema, Pleural; Fatal Outcome; Fluphenazine; Humans; Lung; Male; Middle Aged; Pleura; Pulmonary Edema; Risk Factors; Schizophrenia; Trihexyphenidyl | 1995 |
Two cases of long term dopamine D2 receptor blockade after depot neuroleptics.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Delayed-Action Preparations; Dopamine D2 Receptor Antagonists; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon | 1993 |
Factors affecting rehospitalisation rates of chronic schizophrenic patients living in the community.
Topics: Adult; Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Middle Aged; Neurologic Examination; Patient Compliance; Patient Readmission; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome | 1994 |
Rapidly progressive tardive dyskinesia in AIDS.
Topics: Adult; AIDS Dementia Complex; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Injections, Intramuscular; Male; Neurologic Examination | 1994 |
Platelet dysfunction associated with clozapine therapy.
Topics: Amobarbital; Blood Cell Count; Clozapine; Delayed-Action Preparations; Diazepam; Drug Monitoring; Drug Therapy, Combination; Epistaxis; Fluphenazine; Hemoglobins; Humans; Male; Middle Aged; Platelet Count; Schizophrenia, Paranoid; Thrombocytopenia | 1993 |
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans | 1993 |
Diphenhydramine dependence: a need for awareness.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Diphenhydramine; Fluphenazine; Humans; Male; Schizophrenia; Self Medication; Substance Withdrawal Syndrome; Substance-Related Disorders | 1996 |
Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia | 1995 |
Intervention and social breakdown in the elderly.
Topics: Aged; Combined Modality Therapy; Community Mental Health Services; Ethics, Medical; Female; Fluphenazine; Geriatric Assessment; Humans; Patient Care Team; Schizophrenia; Schizophrenic Psychology; Social Alienation; Social Isolation | 1996 |
Neuroleptic malignant syndrome associated with abrupt withdrawal of anticholinergic agents.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Male; Muscarinic Antagonists; Neuroleptic Malignant Syndrome; Penfluridol; Procyclidine; Schizophrenia; Substance Withdrawal Syndrome; Trihexyphenidyl | 1996 |
Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection.
Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dogs; Fluphenazine; Humans; Sensitivity and Specificity | 1997 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |
Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
Topics: Absorption; Animals; Antipsychotic Agents; Delayed-Action Preparations; Dogs; Female; Fluphenazine; Injections, Intramuscular; Injections, Intravenous; Prodrugs; Sesame Oil | 1997 |
Spiramycin-associated acute dystonia during neuroleptic treatment.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Delayed-Action Preparations; Drug Therapy, Combination; Dystonia; Fluphenazine; Humans; Injections, Intramuscular; Male; Psychotic Disorders; Spiramycin | 1997 |
The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.
Topics: Absorption; Animals; Female; Fluphenazine; Injections, Intramuscular; Lymph Nodes; Muscle, Skeletal; Prodrugs; Rats; Rats, Sprague-Dawley | 1998 |
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors | 1998 |
Alcohol dependence and hospitalization in schizophrenia.
Topics: Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Comorbidity; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Marijuana Abuse; Middle Aged; Patient Readmission; Retrospective Studies; Risk Factors; Schizophrenia; Treatment Refusal | 1999 |
The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia.
Topics: Animals; Antioxidants; Antipsychotic Agents; Delayed-Action Preparations; Disease Models, Animal; Dyskinesia, Drug-Induced; Fluphenazine; Free Radicals; Male; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Vitamin E | 1999 |
Age at onset of schizophrenia and neuroleptic dosage.
Topics: Adult; Age of Onset; Antipsychotic Agents; Clopenthixol; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Schizophrenia; Slovenia | 1999 |
Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys.
Topics: Aggression; Animals; Antipsychotic Agents; Cebus; Dyskinesia, Drug-Induced; Female; Fluphenazine; Locomotion; Male; Prodrugs; Schizophrenia; Stereotyped Behavior; Stress, Physiological | 2001 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia | 2002 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Longitudinal Studies; Schizophrenia, Paranoid | 2003 |
Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Male; Mastication; Prodrugs; Pyrazoles; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Stereotyped Behavior; Substantia Nigra | 2003 |
Rehospitalization risk with second-generation and depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome | 2003 |
Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
Topics: Capillary Action; Chemistry, Pharmaceutical; Flow Injection Analysis; Flupenthixol; Fluphenazine; Haloperidol; Infusions, Parenteral; Medroxyprogesterone Acetate; Rheology; Suspensions; Viscosity | 2004 |
Importance of oral glucose tolerance test in patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Fluphenazine; Glucose Tolerance Test; Humans; Male; Schizophrenia; Weight Gain | 2005 |
Management of psychosis in Australian general practice.
Topics: Adolescent; Adult; Age Factors; Aged; Antimanic Agents; Antipsychotic Agents; Australia; Benzodiazepines; Directive Counseling; Female; Fluphenazine; Humans; Lithium Carbonate; Male; Middle Aged; Olanzapine; Psychotic Disorders; Referral and Consultation; Sex Factors | 2006 |
Adverse extrapyramidal effects in four horse given fluphenazine decanoate.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benztropine; Diphenhydramine; Extrapyramidal Tracts; Fatal Outcome; Female; Fluphenazine; Horse Diseases; Horses; Male; Nervous System Diseases; Treatment Outcome | 2006 |
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Cohort Studies; Fluphenazine; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Reference Values; Risperidone | 2007 |
Who receives long-acting antipsychotic medications?
Topics: Antipsychotic Agents; Black People; Dangerous Behavior; Drug Utilization; Fluphenazine; Humans; Prejudice; Schizophrenia; Socioeconomic Factors; United States; White People | 2007 |
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People | 2007 |
Switching as only temporal solution for patients with antipsychotic-associated diabetes: further observations.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Mass Index; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Diet, Diabetic; Drug Therapy, Combination; Female; Fluphenazine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Mass Screening; Quetiapine Fumarate; Risk Factors; Schizophrenia | 2007 |
Mis-deca-n identity?
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dystonia; Fluphenazine; Humans; Male; Substance-Related Disorders | 2007 |
Early hospital experience with fluphenazine decanoate.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Fluphenazine; Follow-Up Studies; Hospital Records; Humans; Injections; Male; Middle Aged; Patient Compliance; Pharmacy Service, Hospital; Schizophrenia; Treatment Outcome | 1974 |
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Topics: Administration, Oral; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Health Knowledge, Attitudes, Practice; Humans; Long-Term Care; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Yugoslavia | 2008 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia | 2009 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
The challenge of patients with severe psychiatric illness who do not access care - a way forward.
Topics: Antipsychotic Agents; Community Mental Health Services; Female; Fluphenazine; Health Behavior; Health Services Accessibility; Humans; India; Patient Care Team; Primary Health Care; Schizophrenia; Treatment Outcome; Young Adult | 2010 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia | 2013 |
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Medication Adherence; Middle Aged; Schizophrenia | 2013 |
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome | 2013 |
Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration.
Topics: Animals; Chromatography, Liquid; Doping in Sports; Female; Fluphenazine; Horses; Limit of Detection; Sensitivity and Specificity; Substance Abuse Detection; Tandem Mass Spectrometry | 2013 |
Va'a fakalelei 'atamai: restoring the mind in the Kingdom of Tonga.
Topics: Fluphenazine; Kava; Mental Health Services; Psychotic Disorders; Tonga | 2014 |
The effect of fluphenazine decanoate on glucocorticoid production, reproductive cyclicity, and the behavioral stress response in the Persian onager (Equus hemionus onager).
Topics: Animals; Animals, Zoo; Antipsychotic Agents; Cross-Over Studies; Equidae; Estrous Cycle; Female; Fluphenazine; Glucocorticoids; Hydrocortisone; Ovarian Follicle; Progesterone; Random Allocation; Reproduction; Stress, Physiological | 2015 |
Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Female; Fluphenazine; Hip; Humans; Injections, Intramuscular; Muscle, Skeletal; Rhabdomyolysis; Schizophrenia, Paranoid; Time Factors | 2017 |
Delusional infestation successfully controlled with typical antipsychotic depot injection: An illustrative case report.
Topics: Adult; Antipsychotic Agents; Delusional Parasitosis; Diagnosis, Differential; Fluphenazine; Humans; Injections; Malaysia; Male | 2018 |
Fluphenazine decanoate-induced bradycardia: A case report.
Topics: Adult; Antipsychotic Agents; Bradycardia; Delayed-Action Preparations; Fluphenazine; Humans; Male; Schizophrenia | 2022 |
Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
Topics: Butyrylcholinesterase; Decanoates; Fluphenazine; Heptanoates; Humans; Injections, Intramuscular; Prodrugs | 2023 |